StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)

Close on Nov 17, 2026Market cap $642.47MP/E –Yield –

Geron enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Geron's enterprise value was $398.14M on Nov 11, 2026, against $434.31M a year earlier. Over the last 5 years it ranged from $218.98M to $2.61B, with a median of $725.28M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$398.14M-17.2%
2025Dec 31, 2025$480.96M-75.6%
2024Dec 31, 2024$1.97B+139.9%
2023Dec 29, 2023$821.02M+10.0%
2022Dec 30, 2022$746.56M+193.1%
2021Dec 31, 2021$254.67M+41.8%
2020Dec 31, 2020$179.66M+55.0%
2019Dec 31, 2019$115.89M+3401.6%
2018Dec 31, 2018$3.31M-98.8%
2017Dec 29, 2017$276.61M-15.0%
2016Dec 30, 2016$325.50M-56.7%
2015Dec 31, 2015$752.05M+60.5%
2014Dec 31, 2014$468.61M-21.5%
2013Dec 31, 2013$596.79M+267.8%
2012Dec 31, 2012$162.27M-61.9%
2011Jul 29, 2011$426.10M–

More Geron figures

See a number that looks wrong?